RN7SKP289

Across TCGA pan-cancer cohorts, RN7SKP289 RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated RN7SKP289 data layer.

The strongest signal is observed in rectum adenocarcinoma (READ), where higher RN7SKP289 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RN7SKP289 expression acts as an unfavorable survival marker, although some lineages such as ESCA and LAML show a favorable association.

READ, KIRC, and ESCA are the cancer types where RN7SKP289 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
READ	OS	Tertile	All	0.198	0.829	.001	54	view →
KIRC	DFS	Tertile	IV	0.127	0.619	.008	36	view →
ESCA	DFS	Tertile	III,IV	0.783	0.273	.029	24	view →
TGCT	DFS	Tertile	All	0.174	0.801	.041	18	view →
LAML	DFS	Tertile	All	0.905	0.539	.015	18	view →
LUSC	DFS	Tertile	All	0.346	0.711	.044	9	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

RN7SKP289–READ (OS)

Open the READ breakdown →